FIRECREST Customer Support

Did you know the FDA approved its first AI-enabled device in 1995 and now has cleared over 1,000 devices? Yet, there’s still no unique regulatory pathway. Our latest blog explores FDA guidance, lifecycle considerations, ...

ICON’s cardio-metabolic drug development experts are attending the Global CVCT Forum on 8-10 December. Arrange a time to speak with our experts to learn how we support clinical trials across multiple indications, includi...

Antimicrobial resistance (AMR) is a pressing global health and socioeconomic crisis. In the past 5 years, ICON has participated in 400+ infectious disease clinical studies enrolling 483,200+ patients and healthy voluntee...

PLATO is a publicly available, 11-item PRO measure designed to monitor treatment response and symptom progression in adults with obstructive sleep apnea. It’s quick to complete (under 4 minutes), reliable, and validated ...

What does a successful digital endpoint look like? In Duchenne muscular dystrophy trials, stride velocity 95th percentile (SV95C) replaced the 6-minute walk test (6MWT) and secured EMA approval. This case study is a po...

Biotech and pharma sponsors need agile, scalable clinical trial monitoring. Our latest whitepaper explores how decentralised and risk-based models are improving efficiency and site performance. Read more: https://www.i...

Accelerate Your Insights with Symphony FLEX™ Looking for a fast-turn, high-impact investment before year-end? FLEX gives you access to ~300M patient-level records, now with: • Medical payer & remittance data • Snowflake...

As you plan your remaining 2025 budget, consider a solution that accelerates insights across industries: Symphony FLEX™ from Symphony Health, an ICON plc company. FLEX provides market-agnostic, longitudinal patient-leve...

What motivates someone to stay in clinical research for over 20 years? For Victoria DeVeaugh-Geiss, Director of Clinical Operations at ICON, it comes down to one thing: knowing that her work helps bring treatments to pa...

70% of clinical research sites report a rise in study execution burden. Yet, when investigators enjoy a superior sponsor experience, they may enrol twice as many patients. Join our live webinar on 3 December at 10am ET ...

ICON is proud to participate in the SCDM Bogota Single Day Event on 21 November. Join Stephen Cameron, co-chair of the event and Director of Clinical Data Science at ICON, for two thought-provoking sessions. This is a g...

In the latest issue of Journal for Clinical Studies, Dr. Divya S. Mishra outlines the critical components for successful implementation of radiopharmaceutical programs, including: - Specialised infrastructure and isotope...